Search

Your search keyword '"Thompson, Mark G."' showing total 12 results
Start Over Author "Thompson, Mark G." Journal morbidity and mortality weekly report
12 results on '"Thompson, Mark G."'

2. Laboratory-Confirmed COVID-19 Among Adults Hospitalized with COVID-19–Like Illness with Infection-Induced or mRNA Vaccine-Induced SARS-CoV-2 Immunity — Nine States, January–September 2021

Author

Bozio, Catherine H., Grannis, Shaun J., Naleway, Allison L., Ong, Toan C., Butterfield, Kristen A., DeSilva, Malini B., Natarajan, Karthik, Yang, Duck-Hye, Rao, Suchitra, Klein, Nicola P., Irving, Stephanie A., Dixon, Brian E., Dascomb, Kristin, Liao, I-Chia, Reynolds, Sue, McEvoy, Charlene, Han, Jungmi, Reese, Sarah E., Lewis, Ned, Fadel, William F., Grisel, Nancy, Murthy, Kempapura, Ferdinands, Jill, Kharbanda, Anupam B., Mitchell, Patrick K., Goddard, Kristin, Embi, Peter J., Arndorfer, Julie, Raiyani, Chandni, Patel, Palak, Rowley, Elizabeth A., Fireman, Bruce, Valvi, Nimish R., Griggs, Eric P., Levy, Matthew E., Zerbo, Ousseny, Porter, Rachael M., Birch, Rebecca J., Blanton, Lenee, Ball, Sarah W., Steffens, Andrea, Olson, Natalie, Williams, Jeremiah, Dickerson, Monica, McMorrow, Meredith, Schrag, Stephanie J., Verani, Jennifer R., Fry, Alicia M., Azziz-Baumgartner, Eduardo, Barron, Michelle, Gaglani, Manjusha, Thompson, Mark G., and Stenehjem, Edward

Published
2021

3. Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults — Nine States, January–September 2021

Author

Embi, Peter J., Levy, Matthew E., Naleway, Allison L., Patel, Palak, Gaglani, Manjusha, Natarajan, Karthik, Dascomb, Kristin, Ong, Toan C., Klein, Nicola P., Liao, I-Chia, Grannis, Shaun J., Han, Jungmi, Stenehjem, Edward, Dunne, Margaret M., Lewis, Ned, Irving, Stephanie A., Rao, Suchitra, McEvoy, Charlene, Bozio, Catherine H., Murthy, Kempapura, Dixon, Brian E., Grisel, Nancy, Yang, Duck-Hye, Goddard, Kristin, Kharbanda, Anupam B., Reynolds, Sue, Raiyani, Chandni, Fadel, William F., Arndorfer, Julie, Rowley, Elizabeth A., Fireman, Bruce, Ferdinands, Jill, Valvi, Nimish R., Ball, Sarah W., Zerbo, Ousseny, Griggs, Eric P., Mitchell, Patrick K., Porter, Rachael M., Kiduko, Salome A., Blanton, Lenee, Zhuang, Yan, Steffens, Andrea, Reese, Sarah E., Olson, Natalie, Williams, Jeremiah, Dickerson, Monica, McMorrow, Meredith, Schrag, Stephanie J., Verani, Jennifer R., Fry, Alicia M., Azziz-Baumgartner, Eduardo, Barron, Michelle A., Thompson, Mark G., and DeSilva, Malini B.

Published
2021

5. Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December 2020–March 2021

Author

Thompson, Mark G., Burgess, Jefferey L., Naleway, Allison L., Tyner, Harmony L., Yoon, Sarang K., Meece, Jennifer, Olsho, Lauren E.W., Caban-Martinez, Alberto J., Fowlkes, Ashley, Lutrick, Karen, Kuntz, Jennifer L., Dunnigan, Kayan, Odean, Marilyn J., Hegmann, Kurt T., Stefanski, Elisha, Edwards, Laura J., Schaefer-Solle, Natasha, Grant, Lauren, Ellingson, Katherine, Groom, Holly C., Zunie, Tnelda, Thiese, Matthew S., Ivacic, Lynn, Wesley, Meredith G., Lamberte, Julie Mayo, Sun, Xiaoxiao, Smith, Michael E., Phillips, Andrew L., Groover, Kimberly D., Yoo, Young M., Gerald, Joe, Brown, Rachel T., Herring, Meghan K., Joseph, Gregory, Beitel, Shawn, Morrill, Tyler C., Mak, Josephine, Rivers, Patrick, Harris, Katherine M., Hunt, Danielle R., Arvay, Melissa L., Kutty, Preeta, Fry, Alicia M., and Gaglani, Manjusha

Published
2021

7. Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated--VISION Network, 10 States, December 2021-June 2022

Author

Link-Gelles, Ruth, Levy, Matthew E., Gaglani, Manjusha, Irving, Stephanie A., Stockwell, Melissa, Dascomb, Kristin, DeSilva, Malini B., Reese, Sarah E., Liao, I-Chia, Ong, Toan C., Grannis, Shaun J., McEvoy, Charlene, Patel, Palak, Klein, Nicola P., Hartmann, Emily, Stenehjem, Edward, Natarajan, Karthik, Naleway, Allison L., Murthy, Kempapura, Rao, Suchitra, Dixon, Brian E., Kharbanda, Anupam B., Akinseye, Akintunde, Dickerson, Monica, Lewis, Ned, Grisel, Nancy, Han, Jungmi, Barron, Michelle A., Fadel, William F., Dunne, Margaret M., Goddard, Kristin, Arndorfer, Julie, Konatham, Deepika, Valvi, Nimish R., Currey, J.C., Fireman, Bruce, Raiyani, Chandni, Zerbo, Ousseny, Sloan-Aagard, Chantel, Ball, Sarah W., Thompson, Mark G., and Tenforde, Mark W.

Subjects
Medical research, Medicine, Experimental, Messenger RNA, Infection, Adults, Vaccines, Health, University of Colorado
Abstract

On July 15, 2022, this report was posted as an MMWR Early Release on the MMWR website (https://www.cdc.gov/mmwr). The Omicron variant (B.1.1.529) of SARS-CoV-2, the virus that causes COVID-19, was [...]

Published
2022

8. Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5-11 Years and Adolescents Aged 12-15 Years--PROTECT Cohort, July 2021-February 2022

Author

Fowlkes, Ashley L., Yoon, Sarang K., Lutrick, Karen, Gwynn, Lisa, Burns, Joy, Grant, Lauren, Phillips, Andrew L., Ellingson, Katherine, Ferraris, Maria V., LeClair, Lindsay B., Mathenge, Clare, Yoo, Young M., Thiese, Matthew S., Gerald, Lynn B., Solle, Natasha Schaefer, Jeddy, Zuha, Odame-Bamfo, Leah, Mak, Josephine, Hegmann, Kurt T., Gerald, Joe K., Ochoa, Jezahel S., Berry, Mark, Rose, Spencer, Lamberte, Julie Mayo, Madhivanan, Purnima, Pubillones, Felipe A., Rai, Ramona P., Dunnigan, Kayan, Jones, John T., Krupp, Karl, Edwards, Laura J., Bedrick, Edward J., Sokol, Brian E., Lowe, Ashley, McLeland-Wieser, Hilary, Jovel, Krystal S., Fleary, Deanna E., Khan, Sana M., Poe, Brandon, Hollister, James, Lopez, Joanna, Rivers, Patrick, Beitel, Shawn, Tyner, Harmony L., Naleway, Allison L., Olsho, Lauren E.W., Caban-Martinez, Alberto J., Burgess, Jefferey L., Thompson, Mark G., and Gaglani, Manjusha

Subjects
United States. Food and Drug Administration, Pfizer Inc., Messenger RNA, Infection, Vaccines, Pharmaceutical industry, Health, Comirnaty (Vaccine)
Abstract

On March 11, 2022, this report was posted as an MMWR Early Release on the MMWR website (https://www.cdc.gov/mmwr). The BNT162b2 (Pfizer-BioNTech) mRNA COVID-19 vaccine was recommended by CDC's Advisory Committee [...]

Published
2022

9. Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance--VISION Network, 10 States, August 2021-January 2022

Author

Ferdinands, Jill M., Rao, Suchitra, Dixon, Brian E., Mitchell, Patrick K., DeSilva, Malini B., Irving, Stephanie A., Lewis, Ned, Natarajan, Karthik, Stenehjem, Edward, Grannis, Shaun J., Han, Jungmi, McEvoy, Charlene, Ong, Toan C., Naleway, Allison L., Reese, Sarah E., Embi, Peter J., Dascomb, Kristin, Klein, Nicola P., Griggs, Eric P., Konatham, Deepika, Kharbanda, Anupam B., Yang, Duck-Hye, Fadel, William F., Grisel, Nancy, Goddard, Kristin, Patel, Palak, Liao, I-Chia, Birch, Rebecca, Valvi, Nimish R., Reynolds, Sue, Arndorfer, Julie, Zerbo, Ousseny, Murthy, Monica Dickerson Kempapura, Williams, Jeremiah, Bozio, Catherine H., Blanton, Lenee, Verani, Jennifer R., Schrag, Stephanie J., Dalton, Alexandra F., Wondimu, Mehiret H., Link-Gelles, Ruth, Azziz-Baumgartner, Eduardo, Barron, Michelle A., Gaglani, Manjusha, Thompson, Mark G., and Fireman, Bruce

Subjects
Pfizer Inc., Vaccination, Hospitals -- Emergency service, Messenger RNA, Emergency medicine, Adults, Vaccines, Pharmaceutical industry, Health
Abstract

On February 11, 2022, this report was posted as an MMWR Early Release on the MMWR website (https://www.cdc.gov/mmwr). CDC recommends that all persons aged [greater than or equal to] 12 [...]

Published
2022

10. Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19--Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance--VISION Network, 10 States, August 2021-January 2022

Author

Thompson, Mark G., Natarajan, Karthik, Irving, Stephanie A., Rowley, Elizabeth A., Griggs, Eric P., Gaglani, Manjusha, Klein, Nicola P., Grannis, Shaun J., DeSilva, Malini B., Stenehjem, Edward, Reese, Sarah E., Dickerson, Monica, Naleway, Allison L., Han, Jungmi, Konatham, Deepika, McEvoy, Charlene, Rao, Suchitra, Dixon, Brian E., Dascomb, Kristin, Lewis, Ned, Levy, Matthew E., Patel, Palak, Liao, I-Chia, Kharbanda, Anupam B., Barron, Michelle A., Fadel, William F., Grisel, Nancy, Goddard, Kristin, Yang, Duck-Hye, Wondimu, Mehiret H., Murthy, Kempapura, Valvi, Nimish R., Arndorfer, Julie, Fireman, Bruce, Dunne, Margaret M., Embi, Peter, Azziz-Baumgartner, Eduardo, Zerbo, Ousseny, Bozio, Catherine H., Reynolds, Sue, Ferdinands, Jill, Williams, Jeremiah, Link-Gelles, Ruth, Schrag, Stephanie J., Verani, Jennifer R., Ball, Sarah, and Ong, Toan C.

Subjects
Pfizer Inc., Medical research, Medicine, Experimental, Hospitals -- Emergency service, Messenger RNA, Emergency medicine, Adults, Vaccines, Pharmaceutical industry, Health, University of Colorado, Comirnaty (Vaccine)
Abstract

On January 21, 2022, this report was posted as an MMWR Early Release on the MMWR website (https://www.cdc.gov/mmwr). Estimates of COVID-19 mRNA vaccine effectiveness (VE) have declined in recent months [...]

Published
2022

11. Incidence of SARS-CoV-2 Infection, Emergency Department Visits, and Hospitalizations Because of COVID-19 Among Persons Aged [greater than or equal to] 12 Years, by COVID-19 Vaccination Status--Oregon and Washington, July 4-September 25, 2021

Author

Naleway, Allison L., Groom, Holly C., Crawford, Phil M., Salas, S. Bianca, Henningen, Michelle L., Donald, Judy L., Smith, Ning, Thompson, Mark G., Blanton, Lenee H., Bozio, Catherine H., and Azziz-Baumgartner, Eduardo

Subjects
Johnson & Johnson, Pfizer Inc., Medical care -- Utilization, Medical research, Medicine, Experimental, Vaccination, Hospitals -- Emergency service, Infection, Pharmaceutical industry, Health
Abstract

Population-based rates of infection with SARS-CoV-2 (the virus that causes COVID-19) and related health care utilization help determine estimates of COVID-19 vaccine effectiveness and averted illnesses, especially since the SARS-CoV-2 [...]

Published
2021

12. Interim Estimates of COVID-19 Vaccine Effectiveness Against COVID-19-Associated Emergency Department or Urgent Care Clinic Encounters and Hospitalizations Among Adults During SARS-CoV-2 B.1.617.2 (Delta) Variant Predominance--Nine States, June-August 2021

Author

Grannis, Shaun J., Rowley, Elizabeth A., Ong, Toan C., Stenehjem, Edward, Klein, Nicola P., DeSilva, Malini B., Naleway, Allison L., Natarajan, Karthik, and Thompson, Mark G.

Subjects
Pfizer Inc., Medical research, Medicine, Experimental, Hospitals -- Emergency service, Emergency medicine, Adults, Vaccines, Health, University of Colorado, Kaiser Permanente
Abstract

On September 10, 2021, this report was posted as an MMWR Early Release on the MMWR website (https://www.cdc.gov/mmwr). Data on COVID-19 vaccine effectiveness (VE) since the B.1.617.2 (Delta) variant of [...]

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results